BioAge Labs at SfN 2026

Nov 14–18, 2026 Washington, DC ~21k attendees Website

BioAge Labs brings 2 presentations to SfN 2026 in Washington. Its SfN 2026 presentations centre on brain aging, NLRP3 inhibition and biological changes linked to Alzheimer’s disease. One thread examines how an investigational NLRP3 inhibitor shifts plasma risk signatures toward protection.

OrganizationSfN 2026 Attendance
BioAge Labs
Emeryville, CA
bioagelabs.com
Drug developers
Develops medicines targeting biology associated with aging and age-related diseases.
Poster
Mon Nov 16
1–5pm
Poster
Wed Nov 18
1–5pm

Explore the full SfN 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Washington. Leave your work email and we’ll be in touch.

Privacy

Download the full SfN 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from BioAge Labs

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with the Society for Neuroscience. Organization details are derived from SfN’s published exhibitor list, its Neuroscience Meeting Planner and each organization’s own website. Submit a correction